Abstract

The tumor-suppressor genes TSC1 and TSC2 are mutated in tuberous sclerosis, an autosomal dominant multisystem disorder. The gene products of TSC1 and TSC2 form a protein complex that inhibits the signaling of the mammalian target of rapamycin complex1 (mTORC1) pathway. mTORC1 is a crucial molecule in the regulation of cell growth, proliferation and survival. When the TSC1/TSC2 complex is not functional, uncontrolled mTORC1 activity accelerates the cell cycle and triggers tumorigenesis. Recent studies have suggested that TSC1 and TSC2 also regulate the activities of Rac1 and Rho, members of the Rho family of small GTPases, and thereby influence the ensuing actin cytoskeletal organization at focal adhesions. However, how TSC1 contributes to the establishment of cell polarity is not well understood. Here, the relationship between TSC1 and the formation of the actin cytoskeleton was analyzed in stable TSC1-expressing cell lines originally established from a Tsc1-deficient mouse renal tumor cell line. Our analyses showed that cell proliferation and migration were suppressed when TSC1 was expressed. Rac1 activity in these cells was also decreased as was formation of lamellipodia and filopodia. Furthermore, the number of basal actin stress fibers was reduced; by contrast, apical actin fibers, originating at the level of the tight junction formed a network in TSC1-expressing cells. Treatment with Rho-kinase (ROCK) inhibitor diminished the number of apical actin fibers, but rapamycin had no effect. Thus, the actin fibers were regulated by the Rho-ROCK pathway independently of mTOR. In addition, apical actin fibers appeared in TSC1-deficient cells after inhibition of Rac1 activity. These results suggest that TSC1 regulates cell polarity-associated formation of actin fibers through the spatial regulation of Rho family of small GTPases.

Highlights

  • Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome caused by mutation of either TSC1 or TSC2, tumor suppressor genes that encode the proteins TSC1 and TSC2, respectively [1]

  • TSC1 and TSC2 form a complex that negatively regulates the activity of mammalian target of rapamycin by inhibiting Ras homolog enriched in brain (Rheb)

  • TSC1 Inhibits Proliferation of Tsc1-deficient Cells The function of TSC1 was analyzed in CACL1-TSC1 cell lines that stably express TSC1; these cell lines were produced by transfection of the plasmid pIRES-Hygro-rTSC1 into Tsc1deficient CACL1-111 cells

Read more

Summary

Introduction

Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome caused by mutation of either TSC1 or TSC2, tumor suppressor genes that encode the proteins TSC1 (hamartin) and TSC2 (tuberin), respectively [1]. TSC is characterized by the occurrence of benign tumors, or hamartomas, involving multiple organ systems including the central nervous system [2]. Most TSC patients show neurological symptoms, such as seizures, mental retardation and autism [3]. TSC1 and TSC2 form a complex that negatively regulates the activity of mammalian target of rapamycin (mTOR) by inhibiting Ras homolog enriched in brain (Rheb). The active form of Rheb enhances phosphorylation of the mTOR substrates p70 S6 kinase (S6K) and 4E-BP1, and promotes cell growth and proliferation [4,5].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call